Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William A. Barton is active.

Publication


Featured researches published by William A. Barton.


Nature Neuroscience | 2004

Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.

Juha P. Himanen; Michael J. Chumley; Martin Lackmann; Chen Li; William A. Barton; Phillip D. Jeffrey; Christopher Vearing; Detlef Geleick; David A. Feldheim; Andrew W. Boyd; Mark Henkemeyer; Dimitar B. Nikolov

The interactions between Eph receptor tyrosine kinases and their ephrin ligands regulate cell migration and axon pathfinding. The EphA receptors are generally thought to become activated by ephrin-A ligands, whereas the EphB receptors interact with ephrin-B ligands. Here we show that two of the most widely studied of these molecules, EphB2 and ephrin-A5, which have never been described to interact with each other, do in fact bind one another with high affinity. Exposure of EphB2-expressing cells to ephrin-A5 leads to receptor clustering, autophosphorylation and initiation of downstream signaling. Ephrin-A5 induces EphB2-mediated growth cone collapse and neurite retraction in a model system. We further show, using X-ray crystallography, that the ephrin-A5–EphB2 complex is a heterodimer and is architecturally distinct from the tetrameric EphB2–ephrin-B2 structure. The structural data reveal the molecular basis for EphB2–ephrin-A5 signaling and provide a framework for understanding the complexities of functional interactions and crosstalk between A- and B-subclass Eph receptors and ephrins.


Cell | 2005

Adam meets Eph : An ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans

Peter W. Janes; Nayanendu Saha; William A. Barton; Momchil V. Kolev; Sabine H. Wimmer-Kleikamp; Eva Nievergall; Carl P. Blobel; Juha-Pekka Himanen; Martin Lackmann; Dimitar B. Nikolov

The Eph family of receptor tyrosine kinases and their ephrin ligands are mediators of cell-cell communication. Cleavage of ephrin-A2 by the ADAM10 membrane metalloprotease enables contact repulsion between Eph- and ephrin-expressing cells. How ADAM10 interacts with ephrins in a regulated manner to cleave only Eph bound ephrin molecules remains unclear. The structure of ADAM10 disintegrin and cysteine-rich domains and the functional studies presented here define an essential substrate-recognition module for functional interaction of ADAM10 with the ephrin-A5/EphA3 complex. While ADAM10 constitutively associates with EphA3, the formation of a functional EphA3/ephrin-A5 complex creates a new molecular recognition motif for the ADAM10 cysteine-rich domain that positions the proteinase domain for effective ephrin-A5 cleavage. Surprisingly, the cleavage occurs in trans, with ADAM10 and its substrate being on the membranes of opposing cells. Our data suggest a simple mechanism for regulating ADAM10-mediated ephrin proteolysis, which ensures that only Eph bound ephrins are recognized and cleaved.


The EMBO Journal | 2003

Structure and axon outgrowth inhibitor binding of the Nogo‐66 receptor and related proteins

William A. Barton; Betty P. Liu; Dorothea Tzvetkova; Philip D. Jeffrey; Alyson E. Fournier; Dinah W. Y. Sah; Richard L. Cate; Stephen M. Strittmatter; Dimitar B. Nikolov

The myelin‐derived proteins Nogo, MAG and OMgp limit axonal regeneration after injury of the spinal cord and brain. These cell‐surface proteins signal through multi‐subunit neuronal receptors that contain a common ligand‐binding glycosylphosphatidylinositol‐anchored subunit termed the Nogo‐66 receptor (NgR). By deletion analysis, we show that the binding of soluble fragments of Nogo, MAG and NgR to cell‐surface NgR requires the entire leucine‐rich repeat (LRR) region of NgR, but not other portions of the protein. Despite sharing extensive sequence similarity with NgR, two related proteins, NgR2 and NgR3, which we have identified, do not bind Nogo, MAG, OMgp or NgR. To investigate NgR specificity and multi‐ligand binding, we determined the crystal structure of the biologically active ligand‐binding soluble ectodomain of NgR. The molecule is banana shaped with elongation and curvature arising from eight LRRs flanked by an N‐terminal cap and a small C‐terminal subdomain. The NgR structure analysis, as well as a comparison of NgR surface residues not conserved in NgR2 and NgR3, identifies potential protein interaction sites important in the assembly of a functional signaling complex.


Neuron | 2003

Structure of the semaphorin-3A receptor binding module.

Alexander Antipenko; Juha-Pekka Himanen; Klaus van Leyen; Vincenzo Nardi-Dei; Jacob Lesniak; William A. Barton; Kanagalaghatta R. Rajashankar; Min Lu; Claudia Hoemme; Andreas W. Püschel; Dimitar B. Nikolov

The semaphorins are a large group of extracellular proteins involved in a variety of processes during development, including neuronal migration and axon guidance. Their distinctive feature is a conserved 500 amino acid semaphorin domain, a ligand-receptor interaction module also present in plexins and scatter-factor receptors. We report the crystal structure of a secreted 65 kDa form of Semaphorin-3A (Sema3A), containing the full semaphorin domain. Unexpectedly, the semaphorin fold is a variation of the beta propeller topology. Analysis of the Sema3A structure and structure-based mutagenesis data identify the neuropilin binding site and suggest a potential plexin interaction site. Based on the structure, we present a model for the initiation of semaphorin signaling and discuss potential similarities with the signaling mechanisms of other beta propeller cell surface receptors, such as integrins and the LDL receptor.


Molecular Cell | 2010

Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.

Tom C.M. Seegar; Becca Eller; Dorothea Tzvetkova-Robev; Momchil V. Kolev; Scott C. Henderson; Dimitar B. Nikolov; William A. Barton

The Tie family of endothelial-specific receptor tyrosine kinases is essential for cell proliferation, migration, and survival during angiogenesis. Despite considerable similarity, experiments with Tie1- or Tie2-deficient mice highlight distinct functions for these receptors in vivo. The Tie2 receptor is further unique with respect to its structurally homologous ligands. Angiopoietin-2 and -3 can function as agonists or antagonists; angiopoietin-1 and -4 are constitutive agonists. To address the role of Tie1 in angiopoietin-mediated Tie2 signaling and determine the basis for the behavior of the individual angiopoietins, we used an in vivo FRET-based proximity assay to monitor Tie1 and -2 localization and association. We provide evidence for Tie1-Tie2 complex formation on the cell surface and identify molecular surface areas essential for receptor-receptor recognition. We further demonstrate that the Tie1-Tie2 interactions are dynamic, inhibitory, and differentially modulated by angiopoietin-1 and -2. Based on the available data, we propose a unified model for angiopoietin-induced Tie2 signaling.


Nature Structural & Molecular Biology | 2006

Crystal Structures of the Tie2 Receptor Ectodomain and the Angiopoietin-2-Tie2 Complex

William A. Barton; Dorothea Tzvetkova-Robev; Edward P Miranda; Momchil V. Kolev; Kanagalaghatta R Rajashankar; Juha P. Himanen; Dimitar B. Nikolov

The Tie receptor tyrosine kinases and their angiopoietin (Ang) ligands play central roles in developmental and tumor-induced angiogenesis. Here we present the crystal structures of the Tie2 ligand-binding region alone and in complex with Ang2. In contrast to prediction, Tie2 contains not two but three immunoglobulin (Ig) domains, which fold together with the three epidermal growth factor domains into a compact, arrowhead-shaped structure. Ang2 binds at the tip of the arrowhead utilizing a lock-and-key mode of ligand recognition—unique for a receptor kinase—where two complementary surfaces interact with each other with no domain rearrangements and little conformational change in either molecule. Ang2-Tie2 recognition is similar to antibody–protein antigen recognition, including the location of the ligand-binding site within the Ig fold. Analysis of the structures and structure-based mutagenesis provide insight into the mechanism of receptor activation and support the hypothesis that all angiopoietins interact with Tie2 in a structurally similar manner.


The EMBO Journal | 2002

Structural and functional characterization of the Pseudomonas hydroperoxide resistance protein Ohr

Jacob Lesniak; William A. Barton; Dimitar B. Nikolov

Bacteria have developed complex strategies to detoxify and repair damage caused by reactive oxygen species. These compounds, produced during bacterial aerobic respiration as well as by the host immune system cells as a defense mechanism against the pathogenic microorganisms, have the ability to damage nucleic acids, proteins and phospholipid membranes. Here we describe the crystal structure of Pseudomonas aeruginosa Ohr, a member of a recently discovered family of organic hydroperoxide resistance proteins. Ohr is a tightly folded homodimer, with a novel α/β fold, and contains two active sites located at the monomer interface on opposite sides of the molecule. Using in vitro assays, we demonstrate that Ohr functions directly as a hydroperoxide reductase, converting both inorganic and organic hydroperoxides to less toxic metabolites. Site‐directed mutagenesis confirms that the two conserved cysteines in each active site are essential for catalytic activity. We propose that the Ohr catalytic mechanism is similar to that of the structurally unrelated peroxiredoxins, directly utilizing highly reactive cysteine thiol groups to elicit hydroperoxide reduction.


Protein Science | 2003

Structural and functional features of the Escherichia coli hydroperoxide resistance protein OsmC.

Jacob Lesniak; William A. Barton; Dimitar B. Nikolov

The osmotically inducible protein OsmC, like its better‐characterized homolog, the organic hydroperoxide protein Ohr, is involved in defense against oxidative stress caused by exposure to organic hydroperoxides. The crystal structure of Escherichia coli OsmC reported here reveals that the protein is a tightly folded domain‐swapped dimer with two active sites located at the monomer interface on opposite sides of the molecule. We demonstrate that OsmC preferentially metabolizes organic hydroperoxides over inorganic hydrogen peroxide. On the basis of structural and enzymatic similarities, we propose that the OsmC catalytic mechanism is analogous to that of the Ohr proteins and of the structurally unrelated peroxiredoxins, directly using highly reactive cysteine thiol groups to elicit hydroperoxide reduction.


Proceedings of the National Academy of Sciences of the United States of America | 2002

Expanding pyrimidine diphosphosugar libraries via structure-based nucleotidylyltransferase engineering

William A. Barton; John B. Biggins; Jiqing Jiang; Jon S. Thorson; Dimitar B. Nikolov

In vitro “glycorandomization” is a chemoenzymatic approach for generating diverse libraries of glycosylated biomolecules based on natural product scaffolds. This technology makes use of engineered variants of specific enzymes affecting metabolite glycosylation, particularly nucleotidylyltransferases and glycosyltransferases. To expand the repertoire of UDP/dTDP sugars readily available for glycorandomization, we now report a structure-based engineering approach to increase the diversity of α-d-hexopyranosyl phosphates accepted by Salmonella enterica LT2 α-d-glucopyranosyl phosphate thymidylyltransferase (Ep). This article highlights the design rationale, determined substrate specificity, and structural elucidation of three “designed” mutations, illustrating both the success and unexpected outcomes from this type of approach. In addition, a single amino acid substitution in the substrate-binding pocket (L89T) was found to significantly increase the set of α-d-hexopyranosyl phosphates accepted by Ep to include α-d-allo-, α-d-altro-, and α-d-talopyranosyl phosphate. In aggregate, our results provide valuable blueprints for altering nucleotidylyltransferase specificity by design, which is the first step toward in vitro glycorandomization.


Current Biology | 1999

CDC2 ACTIVATION IN FISSION YEAST DEPENDS ON MCS6 AND CSK1, TWO PARTIALLY REDUNDANT CDK-ACTIVATING KINASES (CAKS)

Karen M. Lee; Julia E. Saiz; William A. Barton; Robert P. Fisher

Cyclin-dependent kinases (Cdks) are fully active only when phosphorylated by a Cdk-activating kinase (CAK) [1]. Metazoan CAK is itself a Cdk, Cdk7, whereas the CAK of Saccharomyces cerevisiae is a distinct enzyme unrelated to Cdks [1]. The Mcs6-Mcs2 complex of Schizosaccharomyces pombe is a putative CAK related to the metazoan enzyme [2] [3]. Although the loss of Mcs6 is lethal, it results in a phenotype that is inconsistent with a failure to activate Cdc2, the major Cdk in S. pombe [3]. We therefore tested the ability of Csk1, a putative regulator of Mcs6 [4], to activate Cdk-cyclin complexes in vitro. Csk1 activated both the monomeric and the Mcs2-bound forms of Mcs6. Surprisingly, Csk1 also activated Cdc2 in complexes with either Cdc13 or Cig2 cyclins. When a double mutant carrying a csk1 deletion and a temperature-sensitive mcs6 allele was incubated at the restrictive temperature, Cdc2 was not activated and the cells underwent a cell division arrest prior to mitosis. Cdc2-cyclin complexes isolated from the arrested cells could be activated in vitro by recombinant CAK, whereas complexes from wild-type cells or either of the single mutants were refractory to activation. Thus, fission yeast contains two partially redundant CAKs: the Mcs6-Mcs2 complex and Csk1. Inactivation of both CAKs is necessary and sufficient to prevent Cdc2 activation and cause a cell-cycle arrest. Mcs6, which is essential, may therefore have required functions other than Cdk activation.

Collaboration


Dive into the William A. Barton's collaboration.

Top Co-Authors

Avatar

Dimitar B. Nikolov

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Annamarie C. Dalton

Virginia Commonwealth University

View shared research outputs
Top Co-Authors

Avatar

Jacob Lesniak

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dorothea Tzvetkova-Robev

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Jon S. Thorson

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Juha-Pekka Himanen

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Jiqing Jiang

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

John B. Biggins

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Juha P. Himanen

Memorial Sloan Kettering Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge